New Long-Read Genetic Test Enables Faster and More Comprehensive Diagnosis of Rare Diseases
November 18, 2025
Brand Name :
Seglentis
Synonyms :
celecoxib/tramadol
Class :
NSAID/Opioid Combos, Analgesics
Dosage Forms & Strengths  Â
Tablets (Schedule IV)Â
56mg/44mgÂ
(celecoxib/tramadol)Â
Take 2 tablets having combination of 112 mg celecoxib/88 mg tramadol orally every 12 hours, as required.
Never exceed the limit of suggested dose
Dosage Modifications
Renal impairment
tramadol: Reduced renal function results in a decrease in the rate and scope of discharge of tramadol and its active metabolite
celecoxib: No notable correlation has been observed between GFR and celecoxib clearance there has been no research conducted on patients with severe renal deficiency
Hepatic impairment
Not advisable for mild-to-moderate impaired liver function
For tramadol
In cases of severe liver impairment, the metabolism of tramadol and M1 is decreased, as demonstrated in a study on advanced liver cirrhosis
For celecoxib
celecoxib should not be used in moderate hepatic dysfunction as the combination with tramadol cannot be tailored to individual needs.
In cases of moderate hepatic dysfunction (Child-Pugh B), the dose of celecoxib should be reduced by 50% if used as a standalone medication.
It is not advisable to use celecoxib in cases of severe hepatic dysfunction
Dosing considerations
Carefully observe for any signs of breathing difficulties, particularly during the initial 24 to 72 hours of treatment and following any dosage changes; modify dosage as necessary
Before commencing treatment, take into account the intensity of the pain, the patient's reaction, prior usage of painkillers and any risk factors for addiction, misuse or abuse
Safety and efficacy not determined Â
Refer to adult dosingÂ
Actions and Spectrum:Â
A nonsteroidal anti-inflammatory medicine (NSAID), celecoxib blocks the production of prostaglandins, which are responsible for inflammation and discomfort, by inhibiting the enzyme cyclooxygenase-2 (COX-2).
The main conditions for which celecoxib is prescribed include osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute pain.Â
tramadol, on the other hand, blocks the transmission of pain signals by binding to the mu-opioid receptor in the brain and spinal cord. It is a centrally acting opioid analgesic. tramadol is used to treat moderate to severe pain, including cancer pain, post-operative pain, and neuropathic pain.Â
Frequency defined Â
1-10%Â
Decreased appetite (3.3%)Â
Somnolence (8.2%)Â
>10%Â
Nausea (30.1%)Â
Headache (11.5%)Â
Dizziness (16.9%)Â
Vomiting (15.8%)Â
Post marketing reportsÂ
HypoglycemiaÂ
Movement disorder, speech disorderÂ
Androgen deficiencyÂ
Hypoglycemia, hyponatremiaÂ
Fatal intracranial hemorrhageÂ
Interstitial nephritisÂ
Anaphylactoid reaction, angioedemaÂ
Aseptic meningitis, ageusia, anosmiaÂ
Liver necrosis, hepatitis Â
Pancytopenia, leukopeniaÂ
Severe hyponatremiaÂ
Miosis, mydriasisÂ
Jaundice, hepatic failureÂ
Agranulocytosis, aplastic anemia Â
Serotonin syndromeÂ
DeliriumÂ
Adrenal insufficiencyÂ
QT prolongation
Black Box WarningÂ
A higher risk of cardiovascular events, including heart attacks and strokes, is included in the black box warning for celecoxib. Â
Since tramadol is an opioid, it can be abused and lead to addiction just like other opioids. tramadol use can result in physical or psychological dependence in patients and abuse can cause overdose and death.Â
Contraindication/Caution:Â
Contraindication for celecoxib:Â
Caution for tramadol:Â
Contraindication for tramadol:Â
Caution for tramadol:Â
Pregnancy warnings:    Â
Pregnancy category: N/AÂ
Lactation: Excretion into human milk is known (at low levels for both celecoxib and tramadol)Â
Pregnancy Categories:        Â
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in either the first or second trimester.Â
Category B: There were lack of studies on pregnant women and no evidence of risk to the foetus in animal experiments.  Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.  Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this category
PharmacologyÂ
A nonsteroidal anti-inflammatory medicine (NSAID), celecoxib selectively inhibits the COX-2 enzyme, which oversees generating prostaglandins that cause inflammation and pain. Â
As an opioid analgesic, tramadol blocks the transmission of pain signals by attaching to the mu-opioid receptor in the central nervous system. As tramadol also prevents serotonin and norepinephrine from being reabsorbed, which may help explain why it has analgesic effects.Â
PharmacodynamicsÂ
The COX-1 enzyme, which is necessary for the creation of prostaglandins that protect the gastrointestinal tract and manage renal blood flow, is not severely inhibited by celecoxib. Â
In comparison to other opioids like morphine, tramadol has a reduced affinity for the mu-opioid receptor, which may help explain why it is less likely to be abused and become addictive.Â
PharmacokineticsÂ
Absorption Â
After oral administration, celecoxib is effectively absorbed from the digestive system, with a bioavailability of about 40 to 50%. Celecoxib is not influenced by food in terms of absorption, but when it is taken with food, the peak plasma concentration is postponed by roughly 1 to 2 hours. Following oral administration, tramadol is quickly absorbed from the digestive system and has a bioavailability of about 70%. Food has no impact on how well tramadol is absorbed.Â
DistributionÂ
celecoxib has a volume of distribution of around 400 litres and is largely protein-bound (about 97%). The anti-inflammatory properties of celecoxib are present in the synovial fluid of joints, where it is broadly dispersed throughout the body. tramadol has a volume of distribution of about 2.6 litres per kilogramme and is also very protein bound. The effects of tramadol on pain are felt throughout the body, including in the brain.Â
MetabolismÂ
celecoxib is largely broken down into two primary metabolites in the liver by cytochrome P450 enzymes, especially CYP2C9. These two primary metabolites are then further broken down and removed in the urine and feces. celecoxib has a half-life of approximately 11 hours.
The cytochrome P450 enzymes CYP2D6 and CYP3A4 metabolise tramadol in the liver to create active and inactive metabolites. O-desmethyltramadol (M1), the active metabolite of tramadol, is a strong mu-opioid receptor agonist and greatly contributes to the analgesic effects of the drug. tramadol has a half-life of roughly 6 hours.Â
Elimination and excretionÂ
celecoxib and its metabolites are excreted in the urine, with 27% of the dose being excreted unchanged and 67% of the dose being excreted as metabolites. The tramadol and its metabolites are likewise excreted in the urine, with around 30% of the dosage being removed unaltered and about 60% being eliminated as metabolites.Â
Administration: Â
celecoxib and tramadol are both available in oral formulations as capsules and tablets forms.Â
Patient information leafletÂ
Generic Name: celecoxib/tramadolÂ
Why do we use celecoxib/tramadol?Â
For celecoxib:Â
Treatment of rheumatoid arthritis and osteoarthritisÂ
Treatment of dysmenorrhea and severe discomfortÂ
Patients with familial adenomatous polyposis should avoid developing colon polyps. Â
Acute gouty arthritis treatmentÂ
For tramadol:Â
To treat moderate to severe painÂ
Management of chronic painÂ
Ache that is neuroticÂ
Pain control following surgery, an injury or dental workÂ